Difference between revisions of "MALE5:Volunteer Assignments and Opportunities"

From Compendium of Cancer Genome Aberrations
Jump to navigation Jump to search
VisualWikitext
[checked revision][checked revision]
(Created page with "Welcome! For assignments, please see the "Author" column below (highlighted blue). If empty (no name is present), please volunteer to create content for that disease! To vo...")
 
Line 17: Line 17:
 
!'''Notes'''
 
!'''Notes'''
 
|-
 
|-
 +
|[[MALE5:Clear_cell_renal_cell_carcinoma|Clear cell renal cell carcinoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:Multilocular_cystic_renal_neoplasm_of_low_malignant_potential|Multilocular cystic renal neoplasm of low malignant potential]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:Renal_papillary_adenoma|Renal papillary adenoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:Papillary_renal_cell_carcinoma|Papillary renal cell carcinoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:Oncocytoma_of_the_kidney|Oncocytoma of the kidney]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:Chromophobe_renal_cell_carcinoma|Chromophobe renal cell carcinoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:Other_oncocytic_tumours_of_the_kidney|Other oncocytic tumours of the kidney]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:Collecting_duct_carcinoma|Collecting duct carcinoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:Clear_cell_papillary_renal_cell_tumour|Clear cell papillary renal cell tumour]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:Mucinous_tubular_and_spindle_cell_carcinoma|Mucinous tubular and spindle cell carcinoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:Tubulocystic_renal_cell_carcinoma|Tubulocystic renal cell carcinoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:Acquired_cystic_disease-associated_renal_cell_carcinoma|Acquired cystic disease-associated renal cell carcinoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:Eosinophilic_solid_and_cystic_renal_cell_carcinoma|Eosinophilic solid and cystic renal cell carcinoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:Renal_cell_carcinoma_NOS|Renal cell carcinoma NOS]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:TFE3-rearranged_renal_cell_carcinomas|TFE3-rearranged renal cell carcinomas]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:TFEB-altered_renal_cell_carcinomas|TFEB-altered renal cell carcinomas]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:ELOC_(formerly_TCEB1)-mutated_renal_cell_carcinoma|ELOC (formerly TCEB1)-mutated renal cell carcinoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:Fumarate_hydratase-deficient_renal_cell_carcinoma|Fumarate hydratase-deficient renal cell carcinoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:Succinate_dehydrogenase-deficient_renal_cell_carcinoma|Succinate dehydrogenase-deficient renal cell carcinoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:ALK-rearranged_renal_cell_carcinomas|ALK-rearranged renal cell carcinomas]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:SMARCB1-deficient_renal_medullary_carcinoma|SMARCB1-deficient renal medullary carcinoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:Metanephric_adenoma|Metanephric adenoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:Metanephric_adenofibroma|Metanephric adenofibroma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:Metanephric_stromal_tumour|Metanephric stromal tumour]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:Mixed_epithelial_and_stromal_tumour_of_the_kidney|Mixed epithelial and stromal tumour of the kidney]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:Paediatric_cystic_nephroma|Paediatric cystic nephroma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:Classic_angiomyolipoma_/_PEComa_of_the_kidney|Classic angiomyolipoma / PEComa of the kidney]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:Epithelioid_angiomyolipoma_/_epithelioid_PEComa_of_the_kidney|Epithelioid angiomyolipoma / epithelioid PEComa of the kidney]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:Renal_haemangioblastoma|Renal haemangioblastoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:Juxtaglomerular_cell_tumour|Juxtaglomerular cell tumour]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:Renomedullary_interstitial_cell_tumour|Renomedullary interstitial cell tumour]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:Ossifying_renal_tumour_of_infancy|Ossifying renal tumour of infancy]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:Congenital_mesoblastic_nephroma|Congenital mesoblastic nephroma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:Rhabdoid_tumour_of_the_kidney|Rhabdoid tumour of the kidney]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:Clear_cell_sarcoma_of_the_kidney|Clear cell sarcoma of the kidney]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:Nephrogenic_rests_|Nephrogenic rests]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:Cystic_partially_differentiated_nephroblastoma|Cystic partially differentiated nephroblastoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 
|-
 
|-
−
| ||Disease||
+
|[[MALE5:Nephroblastoma|Nephroblastoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 27: Line 435:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[MALE5:Germ_cell_tumours_of_the_kidney|Germ cell tumours of the kidney]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 36: Line 446:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[MALE5:Urothelial_papilloma|Urothelial papilloma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 45: Line 457:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[MALE5:Inverted_urothelial_papilloma|Inverted urothelial papilloma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 54: Line 468:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[MALE5:Papillary_urothelial_neoplasm_of_low_malignant_potential|Papillary urothelial neoplasm of low malignant potential]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 63: Line 479:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[MALE5:Non-invasive_papillary_urothelial_carcinoma,_low-grade|Non-invasive papillary urothelial carcinoma, low-grade]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 72: Line 490:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[MALE5:Non-invasive_papillary_urothelial_carcinoma,_high-grade|Non-invasive papillary urothelial carcinoma, high-grade]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 81: Line 501:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[MALE5:Urothelial_carcinoma_in_situ|Urothelial carcinoma in situ]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 90: Line 512:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[MALE5:Invasive_urothelial_carcinoma|Invasive urothelial carcinoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 99: Line 523:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[MALE5:Squamous_papilloma_of_the_urothelial_tract|Squamous papilloma of the urothelial tract]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 108: Line 534:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[MALE5:Verrucous_carcinoma_of_the_bladder|Verrucous carcinoma of the bladder]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 117: Line 545:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[MALE5:Pure_squamous_carcinoma_of_the_urothelial_tract|Pure squamous carcinoma of the urothelial tract]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 126: Line 556:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[MALE5:Villous_adenoma|Villous adenoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 135: Line 567:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[MALE5:Adenocarcinoma_NOS|Adenocarcinoma NOS]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 144: Line 578:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[MALE5:Urachal_carcinoma|Urachal carcinoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 153: Line 589:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[MALE5:Diverticular_carcinoma|Diverticular carcinoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 162: Line 600:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[MALE5:Littre_gland_adenocarcinoma_of_the_urethra|Littre gland adenocarcinoma of the urethra]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 171: Line 611:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[MALE5:Skene_gland_adenocarcinoma_of_the_urethra|Skene gland adenocarcinoma of the urethra]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 180: Line 622:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[MALE5:Cowper_gland_adenocarcinoma_of_the_urethra|Cowper gland adenocarcinoma of the urethra]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 189: Line 633:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[MALE5:Clear_cell_adenocarcinoma_of_the_urinary_tract|Clear cell adenocarcinoma of the urinary tract]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 198: Line 644:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[MALE5:Endometrioid_carcinoma_of_the_urinary_tract|Endometrioid carcinoma of the urinary tract]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 207: Line 655:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[MALE5:Prostatic_cystadenoma|Prostatic cystadenoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 216: Line 666:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[MALE5:High-grade_prostatic_intraepithelial_neoplasia|High-grade prostatic intraepithelial neoplasia]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 225: Line 677:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[MALE5:Intraductal_carcinoma_of_the_prostate|Intraductal carcinoma of the prostate]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 234: Line 688:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[MALE5:Prostatic_acinar_adenocarcinoma|Prostatic acinar adenocarcinoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 243: Line 699:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[MALE5:Prostatic_ductal_adenocarcinoma|Prostatic ductal adenocarcinoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:Treatment-related_neuroendocrine_prostatic_carcinoma|Treatment-related neuroendocrine prostatic carcinoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:_Adenosquamous_carcinoma_of_the_prostate| Adenosquamous carcinoma of the prostate]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:_Squamous_cell_carcinoma_of_the_prostate| Squamous cell carcinoma of the prostate]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 252: Line 743:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[MALE5:_Adenoid_cystic_(basal_cell)_carcinoma_of_the_prostate| Adenoid cystic (basal cell) carcinoma of the prostate]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 261: Line 754:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[MALE5:Prostatic_stromal_tumour_of_uncertain_malignant_potential|Prostatic stromal tumour of uncertain malignant potential]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 270: Line 765:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[MALE5:Prostatic_stromal_sarcoma|Prostatic stromal sarcoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 279: Line 776:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[MALE5:Cystadenoma_of_the_seminal_vesicle|Cystadenoma of the seminal vesicle]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 288: Line 787:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[MALE5:Adenocarcinoma_of_the_seminal_vesicle|Adenocarcinoma of the seminal vesicle]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 297: Line 798:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[MALE5:Squamous_cell_carcinoma_of_the_seminal_vesicle|Squamous cell carcinoma of the seminal vesicle]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 306: Line 809:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[MALE5:Mixed_epithelial_and_stromal_tumour_of_the_seminal_vesicle|Mixed epithelial and stromal tumour of the seminal vesicle]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 315: Line 820:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[MALE5:_Germ_cell_neoplasia_in_situ| Germ cell neoplasia in situ]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 324: Line 831:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[MALE5:_Specific_forms_of_intratubular_germ_cell_neoplasia| Specific forms of intratubular germ cell neoplasia]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 333: Line 842:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[MALE5:_Gonadoblastoma| Gonadoblastoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 342: Line 853:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[MALE5:_Seminoma| Seminoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 351: Line 864:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[MALE5:_Embryonal_carcinoma| Embryonal carcinoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 360: Line 875:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[MALE5:_Yolk_sac_tumour,_postpubertal-type| Yolk sac tumour, postpubertal-type]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 369: Line 886:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[MALE5:_Choriocarcinoma| Choriocarcinoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 378: Line 897:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[MALE5:_Placental_site_trophoblastic_tumour| Placental site trophoblastic tumour]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 387: Line 908:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[MALE5:_Epithelioid_trophoblastic_tumour| Epithelioid trophoblastic tumour]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 396: Line 919:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[MALE5:_Cystic_trophoblastic_tumour| Cystic trophoblastic tumour]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 405: Line 930:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[MALE5:Teratoma,_postpubertal-type|Teratoma, postpubertal-type]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 414: Line 941:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[MALE5:Teratoma_with_somatic-type_malignancy|Teratoma with somatic-type malignancy]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 423: Line 952:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[MALE5:_Mixed_germ_cell_tumours| Mixed germ cell tumours]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 432: Line 963:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[MALE5:_Regressed_germ_cell_tumours| Regressed germ cell tumours]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 441: Line 974:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[MALE5:Spermatocytic_tumour|Spermatocytic tumour]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 450: Line 985:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[MALE5:_Teratoma,_prepubertal-type| Teratoma, prepubertal-type]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 459: Line 996:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[MALE5:Yolk_sac_tumour,_prepubertal-type|Yolk sac tumour, prepubertal-type]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 468: Line 1,007:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[MALE5:Testicular_neuroendocrine_tumour,_prepubertal-type|Testicular neuroendocrine tumour, prepubertal-type]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 477: Line 1,018:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[MALE5:Mixed_teratoma_and_yolk_sac_tumour,_prepubertal-type|Mixed teratoma and yolk sac tumour, prepubertal-type]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 486: Line 1,029:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[MALE5:_Leydig_cell_tumour| Leydig cell tumour]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 495: Line 1,040:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[MALE5:_Sertoli_cell_tumour| Sertoli cell tumour]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 504: Line 1,051:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[MALE5:Large_cell_calcifying_Sertoli_cell_tumour|Large cell calcifying Sertoli cell tumour]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 513: Line 1,062:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[MALE5:_Adult_granulosa_cell_tumour| Adult granulosa cell tumour]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 522: Line 1,073:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[MALE5:_Juvenile_granulosa_cell_tumour| Juvenile granulosa cell tumour]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 531: Line 1,084:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[MALE5:_Tumours_in_the_fibroma_thecoma_group| Tumours in the fibroma thecoma group]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 540: Line 1,095:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[MALE5:Mixed_sex_cord_stromal_tumour|Mixed sex cord stromal tumour]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 549: Line 1,106:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[MALE5:Signet_ring_stromal_tumour|Signet ring stromal tumour]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 558: Line 1,117:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[MALE5:Myoid_gonadal_stromal_tumour|Myoid gonadal stromal tumour]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 567: Line 1,128:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[MALE5:Sex_cord_stromal_tumour_NOS|Sex cord stromal tumour NOS]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 576: Line 1,139:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[MALE5:_Serous_cystadenoma| Serous cystadenoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 585: Line 1,150:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[MALE5:_Serous_tumour_of_borderline_malignancy| Serous tumour of borderline malignancy]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 594: Line 1,161:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[MALE5:_Serous_cystadenocarcinoma| Serous cystadenocarcinoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 603: Line 1,172:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[MALE5:_Mucinous_cystadenoma| Mucinous cystadenoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 612: Line 1,183:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[MALE5:_Mucinous_borderline_tumour| Mucinous borderline tumour]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 621: Line 1,194:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[MALE5:_Mucinous_cystadenocarcinoma| Mucinous cystadenocarcinoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 630: Line 1,205:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[MALE5:_Endometrioid_tumours| Endometrioid tumours]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 639: Line 1,216:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[MALE5:_Clear_cell_adenocarcinoma| Clear cell adenocarcinoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 648: Line 1,227:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[MALE5:_Brenner_tumour| Brenner tumour]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 657: Line 1,238:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[MALE5:Adenoma_of_the_collecting_ducts_and_rete_testis|Adenoma of the collecting ducts and rete testis]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 666: Line 1,249:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[MALE5:Adenocarcinoma_of_the_collecting_ducts_and_rete_testis|Adenocarcinoma of the collecting ducts and rete testis]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 675: Line 1,260:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[MALE5:_Adenomatoid_tumour| Adenomatoid tumour]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 684: Line 1,271:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[MALE5:_Well-differentiated_papillary_mesothelial_tumour| Well-differentiated papillary mesothelial tumour]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 693: Line 1,282:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[MALE5:_Mesothelioma| Mesothelioma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 702: Line 1,293:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[MALE5:_Cystadenoma_of_the_epididymis| Cystadenoma of the epididymis]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 711: Line 1,304:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[MALE5:_Papillary_cystadenoma_of_the_epididymis| Papillary cystadenoma of the epididymis]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 720: Line 1,315:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[MALE5:_Adenocarcinoma_of_the_epididymis| Adenocarcinoma of the epididymis]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 729: Line 1,326:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[MALE5:Squamous_cell_carcinoma_of_the_epididymis|Squamous cell carcinoma of the epididymis]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 738: Line 1,337:
 
|
 
|
 
|-
 
|-
 +
|[[MALE5:_Melanotic_neuroectodermal_tumour_of_the_epididymis| Melanotic neuroectodermal tumour of the epididymis]]
 +
|Disease
 
|
 
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:Condyloma_acuminatum|Condyloma acuminatum]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:Penile_intraepithelial_neoplasia,_HPV-associated|Penile intraepithelial neoplasia, HPV-associated]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:Differentiated_penile_intraepithelial_neoplasia,_HPV-independent|Differentiated penile intraepithelial neoplasia, HPV-independent]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:HPV-associated_squamous_cell_carcinoma|HPV-associated squamous cell carcinoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:HPV-independent_squamous_cell_carcinoma|HPV-independent squamous cell carcinoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:_Squamous_cell_carcinoma_NOS| Squamous cell carcinoma NOS]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:_Penile_adenosquamous_and_mucoepidermoid_carcinomas| Penile adenosquamous and mucoepidermoid carcinomas]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:Extramammary_Paget_disease|Extramammary Paget disease]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:Basal_cell_carcinoma_of_the_scrotum|Basal cell carcinoma of the scrotum]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:Well-differentiated_neuroendocrine_tumour|Well-differentiated neuroendocrine tumour]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:Small_cell_neuroendocrine_carcinoma|Small cell neuroendocrine carcinoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:Large_cell_neuroendocrine_carcinoma|Large cell neuroendocrine carcinoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:Mixed_neuroendocrine_neoplasms|Mixed neuroendocrine neoplasms]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:Paraganglioma|Paraganglioma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:The_angiofibroma_family_of_tumours|The angiofibroma family of tumours]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:Solitary_fibrous_tumour|Solitary fibrous tumour]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:Inflammatory_myofibroblastic_tumour|Inflammatory myofibroblastic tumour]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:Haemangioma|Haemangioma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:Angiosarcoma|Angiosarcoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:Glomus_tumour|Glomus tumour]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:Myointimoma|Myointimoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:Myopericytoma|Myopericytoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:Extrarenal_PEComa|Extrarenal PEComa]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:Leiomyoma|Leiomyoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:Leiomyosarcoma|Leiomyosarcoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:Rhabdomyosarcoma|Rhabdomyosarcoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:Synovial_sarcoma|Synovial sarcoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:Extrarenal_rhabdoid_tumour|Extrarenal rhabdoid tumour]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:Desmoplastic_small_round_cell_tumour|Desmoplastic small round cell tumour]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:Extranodal_marginal_zone_lymphoma_of_MALT|Extranodal marginal zone lymphoma of MALT]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:Diffuse_large_B-cell_lymphoma|Diffuse large B-cell lymphoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:Plasmacytoma|Plasmacytoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:_Juvenile_xanthogranuloma| Juvenile xanthogranuloma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:Mucosal_melanoma|Mucosal melanoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:Metastasis_to_the_urinary_tract|Metastasis to the urinary tract]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:Metastasis_to_the_kidney|Metastasis to the kidney]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:Metastasis_to_the_testis_and_paratestis|Metastasis to the testis and paratestis]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:Von_Hippel-Lindau_syndrome|Von Hippel-Lindau syndrome]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:Birt-Hogg-Dube_syndrome|Birt-Hogg-Dube syndrome]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:Hereditary_papillary_renal_carcinoma|Hereditary papillary renal carcinoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:Hereditary_leiomyomatosis_and_renal_cell_carcinoma_syndrome|Hereditary leiomyomatosis and renal cell carcinoma syndrome]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:Succinate_dehydrogenase-deficient_tumour_syndromes|Succinate dehydrogenase-deficient tumour syndromes]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:BAP1_tumour_predisposition_syndrome|BAP1 tumour predisposition syndrome]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:Hereditary_phaeochromocytoma-paraganglioma_syndromes|Hereditary phaeochromocytoma-paraganglioma syndromes]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:Tuberous_sclerosis|Tuberous sclerosis]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:Genitourinary_system_and_Lynch_syndrome|Genitourinary system and Lynch syndrome]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:Hereditary_tumour_syndromes_associated_with_homologous_recombination_pathway_mutations|Hereditary tumour syndromes associated with homologous recombination pathway mutations]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:Carney_complex|Carney complex]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:Peutz-Jeghers_syndrome|Peutz-Jeghers syndrome]]
 
|Disease
 
|Disease
 
|
 
|

Revision as of 14:06, 25 February 2024

Welcome!

For assignments, please see the "Author" column below (highlighted blue).

If empty (no name is present), please volunteer to create content for that disease!

To volunteer, please [Contact us] with your page of interest.

WHO Classification of Urinary and Male Genital Tumours (5th Edition) Content
Disease Page Type Author Date Assigned to Author Target Completion Date Author Content (Pending or Complete) Date Completed by Author Associate Editor Date of Last Editor Review Notes
Clear cell renal cell carcinoma Disease
Multilocular cystic renal neoplasm of low malignant potential Disease
Renal papillary adenoma Disease
Papillary renal cell carcinoma Disease
Oncocytoma of the kidney Disease
Chromophobe renal cell carcinoma Disease
Other oncocytic tumours of the kidney Disease
Collecting duct carcinoma Disease
Clear cell papillary renal cell tumour Disease
Mucinous tubular and spindle cell carcinoma Disease
Tubulocystic renal cell carcinoma Disease
Acquired cystic disease-associated renal cell carcinoma Disease
Eosinophilic solid and cystic renal cell carcinoma Disease
Renal cell carcinoma NOS Disease
TFE3-rearranged renal cell carcinomas Disease
TFEB-altered renal cell carcinomas Disease
ELOC (formerly TCEB1)-mutated renal cell carcinoma Disease
Fumarate hydratase-deficient renal cell carcinoma Disease
Succinate dehydrogenase-deficient renal cell carcinoma Disease
ALK-rearranged renal cell carcinomas Disease
SMARCB1-deficient renal medullary carcinoma Disease
Metanephric adenoma Disease
Metanephric adenofibroma Disease
Metanephric stromal tumour Disease
Mixed epithelial and stromal tumour of the kidney Disease
Paediatric cystic nephroma Disease
Classic angiomyolipoma / PEComa of the kidney Disease
Epithelioid angiomyolipoma / epithelioid PEComa of the kidney Disease
Renal haemangioblastoma Disease
Juxtaglomerular cell tumour Disease
Renomedullary interstitial cell tumour Disease
Ossifying renal tumour of infancy Disease
Congenital mesoblastic nephroma Disease
Rhabdoid tumour of the kidney Disease
Clear cell sarcoma of the kidney Disease
Nephrogenic rests Disease
Cystic partially differentiated nephroblastoma Disease
Nephroblastoma Disease
Germ cell tumours of the kidney Disease
Urothelial papilloma Disease
Inverted urothelial papilloma Disease
Papillary urothelial neoplasm of low malignant potential Disease
Non-invasive papillary urothelial carcinoma, low-grade Disease
Non-invasive papillary urothelial carcinoma, high-grade Disease
Urothelial carcinoma in situ Disease
Invasive urothelial carcinoma Disease
Squamous papilloma of the urothelial tract Disease
Verrucous carcinoma of the bladder Disease
Pure squamous carcinoma of the urothelial tract Disease
Villous adenoma Disease
Adenocarcinoma NOS Disease
Urachal carcinoma Disease
Diverticular carcinoma Disease
Littre gland adenocarcinoma of the urethra Disease
Skene gland adenocarcinoma of the urethra Disease
Cowper gland adenocarcinoma of the urethra Disease
Clear cell adenocarcinoma of the urinary tract Disease
Endometrioid carcinoma of the urinary tract Disease
Prostatic cystadenoma Disease
High-grade prostatic intraepithelial neoplasia Disease
Intraductal carcinoma of the prostate Disease
Prostatic acinar adenocarcinoma Disease
Prostatic ductal adenocarcinoma Disease
Treatment-related neuroendocrine prostatic carcinoma Disease
Adenosquamous carcinoma of the prostate Disease
Squamous cell carcinoma of the prostate Disease
Adenoid cystic (basal cell) carcinoma of the prostate Disease
Prostatic stromal tumour of uncertain malignant potential Disease
Prostatic stromal sarcoma Disease
Cystadenoma of the seminal vesicle Disease
Adenocarcinoma of the seminal vesicle Disease
Squamous cell carcinoma of the seminal vesicle Disease
Mixed epithelial and stromal tumour of the seminal vesicle Disease
Germ cell neoplasia in situ Disease
Specific forms of intratubular germ cell neoplasia Disease
Gonadoblastoma Disease
Seminoma Disease
Embryonal carcinoma Disease
Yolk sac tumour, postpubertal-type Disease
Choriocarcinoma Disease
Placental site trophoblastic tumour Disease
Epithelioid trophoblastic tumour Disease
Cystic trophoblastic tumour Disease
Teratoma, postpubertal-type Disease
Teratoma with somatic-type malignancy Disease
Mixed germ cell tumours Disease
Regressed germ cell tumours Disease
Spermatocytic tumour Disease
Teratoma, prepubertal-type Disease
Yolk sac tumour, prepubertal-type Disease
Testicular neuroendocrine tumour, prepubertal-type Disease
Mixed teratoma and yolk sac tumour, prepubertal-type Disease
Leydig cell tumour Disease
Sertoli cell tumour Disease
Large cell calcifying Sertoli cell tumour Disease
Adult granulosa cell tumour Disease
Juvenile granulosa cell tumour Disease
Tumours in the fibroma thecoma group Disease
Mixed sex cord stromal tumour Disease
Signet ring stromal tumour Disease
Myoid gonadal stromal tumour Disease
Sex cord stromal tumour NOS Disease
Serous cystadenoma Disease
Serous tumour of borderline malignancy Disease
Serous cystadenocarcinoma Disease
Mucinous cystadenoma Disease
Mucinous borderline tumour Disease
Mucinous cystadenocarcinoma Disease
Endometrioid tumours Disease
Clear cell adenocarcinoma Disease
Brenner tumour Disease
Adenoma of the collecting ducts and rete testis Disease
Adenocarcinoma of the collecting ducts and rete testis Disease
Adenomatoid tumour Disease
Well-differentiated papillary mesothelial tumour Disease
Mesothelioma Disease
Cystadenoma of the epididymis Disease
Papillary cystadenoma of the epididymis Disease
Adenocarcinoma of the epididymis Disease
Squamous cell carcinoma of the epididymis Disease
Melanotic neuroectodermal tumour of the epididymis Disease
Condyloma acuminatum Disease
Penile intraepithelial neoplasia, HPV-associated Disease
Differentiated penile intraepithelial neoplasia, HPV-independent Disease
HPV-associated squamous cell carcinoma Disease
HPV-independent squamous cell carcinoma Disease
Squamous cell carcinoma NOS Disease
Penile adenosquamous and mucoepidermoid carcinomas Disease
Extramammary Paget disease Disease
Basal cell carcinoma of the scrotum Disease
Well-differentiated neuroendocrine tumour Disease
Small cell neuroendocrine carcinoma Disease
Large cell neuroendocrine carcinoma Disease
Mixed neuroendocrine neoplasms Disease
Paraganglioma Disease
The angiofibroma family of tumours Disease
Solitary fibrous tumour Disease
Inflammatory myofibroblastic tumour Disease
Haemangioma Disease
Angiosarcoma Disease
Glomus tumour Disease
Myointimoma Disease
Myopericytoma Disease
Extrarenal PEComa Disease
Leiomyoma Disease
Leiomyosarcoma Disease
Rhabdomyosarcoma Disease
Synovial sarcoma Disease
Extrarenal rhabdoid tumour Disease
Desmoplastic small round cell tumour Disease
Extranodal marginal zone lymphoma of MALT Disease
Diffuse large B-cell lymphoma Disease
Plasmacytoma Disease
Juvenile xanthogranuloma Disease
Mucosal melanoma Disease
Metastasis to the urinary tract Disease
Metastasis to the kidney Disease
Metastasis to the testis and paratestis Disease
Von Hippel-Lindau syndrome Disease
Birt-Hogg-Dube syndrome Disease
Hereditary papillary renal carcinoma Disease
Hereditary leiomyomatosis and renal cell carcinoma syndrome Disease
Succinate dehydrogenase-deficient tumour syndromes Disease
BAP1 tumour predisposition syndrome Disease
Hereditary phaeochromocytoma-paraganglioma syndromes Disease
Tuberous sclerosis Disease
Genitourinary system and Lynch syndrome Disease
Hereditary tumour syndromes associated with homologous recombination pathway mutations Disease
Carney complex Disease
Peutz-Jeghers syndrome Disease
Retrieved from "https://ccga.io/index.php?title=MALE5:Volunteer_Assignments_and_Opportunities&oldid=14254"